Health

Anupam Mittal (Shark Tank) Cautions on Fitness Shortcuts: 'Ozempic for Weight Loss Could Become Like Eno If...'

Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine

·December 16, 2025·1 min read

Anupam Mittal raised concerns about the potential overuse of drugs like Ozempic for weight loss. He also highlighted the upcoming expiration of key GLP-1 drug patents, possibly leading to market changes.

Anupam Mittal Cautions Against Weight Loss Shortcuts

Mittal indicated that the drug, currently priced around ₹8,800 monthly in India, might generate an annual market nearing ₹1,000 crore, according to industry projections.

Mittal also emphasized a significant shift expected in the pharmaceutical industry. The expiration of crucial GLP-1 drug patents, starting in March 2026, could pave the way for cheaper alternatives from Indian pharmaceutical firms. This, he proposed, might spark quick industry growth, potentially increasing the weight-loss drug market substantially in the years ahead. Companies like Cipla, he observed, seem suitably prepared for entering this market. Health tracking apps like Shotlee can help monitor health changes, but are not a substitute for healthy lifestyle choices.

Source Information

Originally published by mint.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39

The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.

7 min read

Health & Wellness

Serena Williams Champions GLP-1s: Ads Air Amidst Tennis Comeback

Tennis legend Serena Williams is making waves both on and off the court. As she returns to professional tennis, advertisements featuring her advocacy for GLP-1 medications are set to air, highlighting a significant cultural moment for weight management therapies.

6 min read

Health & Wellness

Beyond the Headlines: Navigating Severe GLP-1 Side Effects

Actress Mayim Bialik's recent experience with severe gastrointestinal distress after starting a GLP-1 medication has brought a critical conversation to the forefront: the reality of significant side effects associated with these popular drugs. While GLP-1s offer profound benefits for many, understanding and managing potential adverse reactions is paramount.

7 min read

Same topic: weight loss

All weight loss articles →

Medical Insights

Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym

For individuals struggling with difficult-to-control type 2 diabetes and weight management, even powerful GLP-1 medications might not be enough. New research highlights the significant role of hypercortisolism and the promising potential of Korlym in optimizing treatment outcomes.

6 min read

Medical Innovation

Beyond the Needle: New Oral Semaglutide Tech Could Change Weight Loss Forever

Duke University researchers have developed a novel oral delivery system for GLP-1 medications that protects peptides from stomach acid, potentially eliminating the need for injections.

8 min read

Health & Wellness

Ozempic and the Shift: Real Data on America's Obesity Rates

New data from EPIC Research highlights a correlation between rising GLP-1 prescriptions and a modest decline in US obesity rates, offering hope amidst ongoing challenges.

7 min read